1. Home
  2. ACNT vs CRDL Comparison

ACNT vs CRDL Comparison

Compare ACNT & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

N/A

Current Price

$15.21

Market Cap

118.8M

Sector

Industrials

ML Signal

N/A

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNT
CRDL
Founded
1945
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.8M
97.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACNT
CRDL
Price
$15.21
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
84.6K
688.9K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$171,413,000.00
N/A
Revenue This Year
$22.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$161.57
N/A
Revenue Growth
65.05
N/A
52 Week Low
$10.76
$0.77
52 Week High
$15.69
$1.59

Technical Indicators

Market Signals
Indicator
ACNT
CRDL
Relative Strength Index (RSI) 68.35 57.41
Support Level $14.74 $0.88
Resistance Level $15.69 $1.06
Average True Range (ATR) 0.59 0.08
MACD 0.02 0.01
Stochastic Oscillator 76.54 89.58

Price Performance

Historical Comparison
ACNT
CRDL

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: